These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16313957)

  • 1. Designing pregnancy centered medications: drugs which do not cross the human placenta.
    Gedeon C; Koren G
    Placenta; 2006 Aug; 27(8):861-8. PubMed ID: 16313957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental drug transporters and their role in fetal protection.
    Iqbal M; Audette MC; Petropoulos S; Gibb W; Matthews SG
    Placenta; 2012 Mar; 33(3):137-42. PubMed ID: 22265855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta.
    Gedeon C; Anger G; Lubetsky A; Miller MP; Koren G
    J Obstet Gynaecol; 2008 Jul; 28(5):485-9. PubMed ID: 18850420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs.
    Myllynen P; Pienimäki P; Vähäkangas K
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):489-94. PubMed ID: 16023691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.
    Staud F; Cerveny L; Ceckova M
    J Drug Target; 2012 Nov; 20(9):736-63. PubMed ID: 22994411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transporters in placental transfer of drugs.
    Ganapathy V; Prasad PD
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):381-7. PubMed ID: 15979662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein in the placenta: expression, localization, regulation and function.
    Ceckova-Novotna M; Pavek P; Staud F
    Reprod Toxicol; 2006 Oct; 22(3):400-10. PubMed ID: 16563694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety.
    Kraemer J; Klein J; Lubetsky A; Koren G
    Am J Obstet Gynecol; 2006 Jul; 195(1):270-4. PubMed ID: 16579925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational Age-Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics.
    Anoshchenko O; Prasad B; Neradugomma NK; Wang J; Mao Q; Unadkat JD
    Drug Metab Dispos; 2020 Sep; 48(9):735-741. PubMed ID: 32591415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications.
    DeVane CL
    NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838
    [No Abstract]   [Full Text] [Related]  

  • 11. The Placental Barrier: the Gate and the Fate in Drug Distribution.
    Tetro N; Moushaev S; Rubinchik-Stern M; Eyal S
    Pharm Res; 2018 Feb; 35(4):71. PubMed ID: 29476301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer.
    Pollex EK; Feig DS; Koren G
    J Matern Fetal Neonatal Med; 2010 Mar; 23(3):224-8. PubMed ID: 20064105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-20th century evidence for the placental passage of drugs.
    Jack D
    Drug News Perspect; 2005 Apr; 18(3):222-4. PubMed ID: 15915225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human placenta--an alternative for studying foetal exposure.
    Myren M; Mose T; Mathiesen L; Knudsen LE
    Toxicol In Vitro; 2007 Oct; 21(7):1332-40. PubMed ID: 17624715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of placental drug transport].
    Abucewicz A; Abucewicz M; Szyszka K
    Pol Tyg Lek; 1971 Jul; 26(30):1174-6. PubMed ID: 4937317
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies.
    Prouillac C; Lecoeur S
    Drug Metab Dispos; 2010 Oct; 38(10):1623-35. PubMed ID: 20606001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental drug transporters.
    Unadkat JD; Dahlin A; Vijay S
    Curr Drug Metab; 2004 Feb; 5(1):125-31. PubMed ID: 14965255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological changes during pregnancy and their implications for pharmacological treatment.
    Redmond GP
    Clin Invest Med; 1985; 8(4):317-22. PubMed ID: 4075616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in drug disposition during pregnancy: implications for drug therapy.
    Hodge LS; Tracy TS
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):557-71. PubMed ID: 17696806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug transfer and metabolism by the human placenta.
    Syme MR; Paxton JW; Keelan JA
    Clin Pharmacokinet; 2004; 43(8):487-514. PubMed ID: 15170365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.